Fig. 5. Average spectral power during nonrapid eye movement sleep at baseline (black ), and after 6 h of exposure to sevoflurane (yellow ), isoflurane (purple ), or halothane (red ) over (A ) L2, the second portion of the light cycle; (B ) D1, the first portion of the dark cycle; and (C ) D2, the second portion of the dark cycle.